Aesculap AG Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Kelayres PA United States (1977)
Status: No NME R&D (1977)

Organization Overview

First Clinical Trial
2010
NCT00918619
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Aesculap Biologics, LLC | Aesculape CRO Belgium BV | Aesculap Implant Systems